Spirochromanone derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S017000, C544S124000, C544S333000, C544S360000, C514S232800, C514S253030, C514S256000

Reexamination Certificate

active

07410976

ABSTRACT:
The invention relates to a compound of a formula (I):or a pharmaceutically acceptable salt or ester thereof, useful as a therapeutic agent for various ACC-related disorders.

REFERENCES:
patent: 5206240 (1993-04-01), Baldwin et al.
patent: 5633247 (1997-05-01), Baldwin et al.
patent: 5885999 (1999-03-01), Elliott et al.
patent: 004624 (1979-03-01), None
patent: 2005-119987 (2005-12-01), None
patent: WO 94/17045 (1994-08-01), None
patent: WO 95/30642 (1995-11-01), None
patent: WO 96/39140 (1996-12-01), None
patent: WO 2004/092179 (2004-10-01), None
patent: WO 2006/055752 (2006-05-01), None
Database Chemcats Abstract XP002407688, CAS-registry No.: 877811-12-6, 877811-11-5 & “Interchim Intermediates”, Jan. 18, 2005.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Spirochromanone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spirochromanone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spirochromanone derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4017418

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.